Advertisement

Topics

Meningococcal Conjugates Vaccine - Biotech, Pharma and Life Science Channel

04:08 EST 6th February 2016 | BioPortfolio

PubMed Articles [2005 Associated PubMed Articles listed on BioPortfolio]

Imitation dynamics of vaccine decision-making behaviours based on the game theory.

Based on game theory, we propose an age-structured model to investigate the imitation dynamics of vaccine uptake. We first obtain the existence and local stability of equilibria. We show that Hopf bif...

HPV vaccine introduction in Rwanda: Impacts on the broader health system.

Rwanda was the first country in Africa to introduce the human papillomavirus (HPV) vaccine. This was achieved through multi-year school-based campaigns. Our study evaluated the impact of the HPV vacci...

Fluorescent Rhodamines and Fluorogenic Carbopyronines for Super-Resolution STED Microscopy in Living Cells.

A range of bright and photostable rhodamines and carbopyronines with absorption maxima in the range of λ=500-630 nm were prepared, and enabled the specific labeling of cytoskeletal filaments using ...

Site-Specific Thiol-mediated PEGylation of Streptokinase Leads to Improved Properties with Clinical Potential.

Streptokinase (SK) is an efficient thrombolytic agent that dissolves fibrin blood clots with clinical efficiency comparable to the high priced drug, tissue plasminogen activator (tPA). However, being ...

Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.

To assess the immunogenicity and safety of influenza vaccine in patients with systemic lupus erythematosus (SLE).

Electrophilicities and protein covalent binding of demethylation metabolites of colchicine.

Colchicine (COL), an alkaloid existing in plants of Liliaceous colchicum, has been widely used in the treatment of gout and familial Mediterranean fever. The administration of COL was found to cause l...

Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4+ T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host.

Ehrlichia chaffeensis is a tick-borne rickettsial pathogen and the causative agent of human monocytic ehrlichiosis. Transmitted by the Amblyomma americanum tick, E. chaffeensis also causes disease in ...

Proteome targets of ubiquitin-like samp1ylation are associated with sulfur metabolism and oxidative stress in Haloferax volcanii.

Small archaeal modifier proteins (SAMPs) are related to ubiquitin in tertiary structure and in their isopeptide linkage to substrate proteins. SAMPs also function in sulfur mobilization to form biomol...

Multifunctional nanoparticle-protein conjugates with controllable bioactivity and pH responsiveness.

The modulation of protein activity is of significance for disease therapy, molecular diagnostics, and tissue engineering. Nanoparticles offer a new platform for the preparation of protein conjugates w...

Preventing Infections in Sickle Cell Disease: The Unfinished Business.

While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multi...

News Articles [2295 Associated News Articles listed on BioPortfolio]

An integrated practical implementation of continuous aqueous two‐phase systems for the recovery of human IgG: From the microdevice to a multistage bench‐scale mixer‐settler device.

Aqueous two‐phase systems (ATPS) are a liquid‐liquid extraction technology with clear process benefits; however, its lack of industrial embracement is still a challenge to overcome. Antibodies are...

MedImmune announces FDA approval of first four-strain flu vaccine, Flumist® Quadrivalent

MedImmune announced on Tuesday 13th March that the U.S. Food and Drug Administration (FDA) has approved FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) for prevention of influenza.&nb...

Flu vaccines to be given to all children

All two to 17-year-olds in the UK are to be offered flu vaccinations each winter in a significant shift in UK immunisation policy. Up to nine million children will be eligible for a new nasal spray va...

Regional Growth Fund - Round 5

The life science sector is benefiting from funding secured in previous rounds of RGF. Areas as diverse as R&D, pharmaceutical manufacturing, medical technologies, vaccine manufacture, animal heal...

Mewburn Ellis LLP congratulates long-term client, Spirogen, on their acquisition by AstraZeneca’s MedImmune

Mewburn Ellis LLP are delighted that the acquisition of Spirogen by MedImmune from Auven Therapeutics for $200 million has been successfully concluded. The deal also involved a deferred consideration...

Patients with cryopyrin-associated periodic syndromes may react to S pneumoniae vaccine

Seven consecutive patients with cryopyrin-associated periodic syndrome experienced severe inflammation following receipt of a Streptococcus pneumoniae vaccination, according to a recently published re...

Additional Funding Secured for Affinivax's Pneumococcal Vaccine

NewsAffinivax secures additional funding to advance its novel pneumococcal vaccine towards clinical trials.

Microbix developing program to combat Zika virus

Microbix Biosystems (TSX:MBX) has made plans to develop and introduce new products for use in diagnostic tests and vaccine research in response to the emergent Zika virus, which is spreading throughou...

Nordic Nanovector to Present at the Swiss-Scandinavian Bio-Business Seminar on 10 February 2016

Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialization of novel targeted therapeutics in haematology and oncology, announces that its CFO T...

[Seminar] Clonorchiasis

On Aug 21, 1875, James McConnell published in The Lancet his findings from a post-mortem examination of a 20-year-old Chinese man—undertaken at the Medical College Hospital in Calcutta, India—in w...

Events [0 Results]

None

Companies [107 Associated Companies listed on BioPortfolio]

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a pate...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allo...

VaxAlta Inc.

VaxAlta is a leading glycoconjugate vaccine research and development company based in Edmonton, Alberta. Founded in 2013, the company is focused on developing sugar-based, effecti...

IDT Biologika

IDT Biologika is an innovative, privately-held life science company with more than 94 years history and expertise in Research, Development and Manufacturing of biologics for the g...

ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides control...

AVAX Technologies, Inc.

AVAX Technologies, Inc. is a biotechnology company with operations in the United States and Europe. The Company is engaged in the research, clinical and commercial development of ...

EY Laboratories inc

Manufacturer of biochemical reagents serving the needs of biochemical research in glycobiology, immunology, and microbiology. Manufacturer of rapid, simple, and stable diagnostic test kits for visual ...

Aduro BioTech, Inc.

Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of at...

Clinical Trials [2467 Associated Clinical Trials listed on BioPortfolio]

Vaccine Efficacy in Diabetic and Elderly Patients

This study evaluates the effectiveness of the seasonal flu vaccine in adults of different ages and diabetic disease statuses. These studies will help our understanding of how chronic infla...

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Many plasma donation centers have Tetanus immunization programs that are implemented in order to collect plasma with high levels of tetanus antibodies. The immunization program requires pa...

Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC

This is a randomized, open-label, phaseⅡ study evaluating efficacy and safety of DC (dendritic cells) vaccine concurrent with chemotherapy compared to chemotherapy alone in patients with...

Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults

The purpose of this study is to evaluate the efficacy of the Norovirus (NoV) GI.1/GII.4 Bivalent Virus-Like Particle Vaccine against moderate or severe acute gastroenteritis (AGE) due to g...

Evaluation of an Intervention PROMOting VAccination in Maternity in Quebec

Vaccination greatly reduced mortality and morbidity from many preventable diseases. However, to avoid the resurgence of these diseases and the human drama associated, high vaccine coverage...

Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.

The purpose of this study is collect safety information on the use of Fluarix Tetra according to the approved PI, over a period of 6 years from children (over 3 years of age) and adults in...

Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso

This study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation trial of Sanaria's irradiated sporozoite vaccine (PfSPZ vaccine). The primary objective of this proto...

mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau

The question that this project seeks to answer, is whether mobile phones can be used to increase the measles vaccination coverage and timeliness in Guinea-Bissau. The intervention will be ...

The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines

This study is designed to estimate the changes in the etiology and epidemiology of acute gastroenteritis in children aged less than 18 years after the implementation of rotavirus vaccine i...

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population

The purpose of this study is to further develop a formulation and dose regimen of the norovirus GI.1/GII.4 bivalent virus-like particle (VLP) vaccine that is immunogenic and safe in an eld...

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)

Quick Search
Advertisement
 
review and buy Meningococcal Conjugates Vaccine market research data and corporate reports here

Channels Quicklinks